U.S. Markets closed

Pluristem Therapeutics Inc. (PSTI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.0000+0.0400 (+1.35%)
At close: 4:00PM EDT
3.0900 +0.09 (3.00%)
After hours: 06:44PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.34
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.8500
52 Week Low 32.8100
50-Day Moving Average 33.0809
200-Day Moving Average 33.9851

Share Statistics

Avg Vol (3 month) 3229.88k
Avg Vol (10 day) 3142.82k
Shares Outstanding 531.74M
Implied Shares Outstanding 6N/A
Float 27.35M
% Held by Insiders 113.92%
% Held by Institutions 120.05%
Shares Short (Jul 14, 2021) 4598.62k
Short Ratio (Jul 14, 2021) 42.41
Short % of Float (Jul 14, 2021) 42.67%
Short % of Shares Outstanding (Jul 14, 2021) 41.89%
Shares Short (prior month Jun 14, 2021) 4306.05k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 24, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul 24, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.49%
Return on Equity (ttm)-105.54%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)23k
EBITDA -43.16M
Net Income Avi to Common (ttm)-43.43M
Diluted EPS (ttm)-1.6630
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.37M
Total Cash Per Share (mrq)1.49
Total Debt (mrq)995k
Total Debt/Equity (mrq)1.46
Current Ratio (mrq)5.02
Book Value Per Share (mrq)2.15

Cash Flow Statement

Operating Cash Flow (ttm)-27.64M
Levered Free Cash Flow (ttm)-12.6M